Low Molecular Weight Protamine - Basic Principles and Clinical Practice

By Byun Y.   Singh V.K.   Yang V.C.  

Thrombosis Research, Vol. 94, Iss. 1, 1999-04 ,pp. : 53-61

Elsevier

Access to resources Recommend Favorite

The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.

By Holst J.   Lindblad B.   Bergqvist D.   Hedner U.   Nordfang O.   Ostergaard P.  

Thrombosis Research, Vol. 86, Iss. 4, 1997-05 ,pp. : 343-348

Elsevier

Access to resources Recommend Favorite

A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents

By Mahan Charles  

Journal of Thrombosis and Thrombolysis, Vol. 37, Iss. 3, 2014-04 ,pp. : 271-278

Springer Publishing Company

Access to resources Recommend Favorite

Magnetic Bead Protamine-Linked Microtiter Assay for Detection of Heparin using Iodinated Low-Molecular-Mass Heparin-Tyramine

By Harenberg J.   Lohr G.   Malsch R.   Heene D.L.   Guerrini M.   Torri G.   Casu B.  

Thrombosis Research, Vol. 79, Iss. 2, 1995-07 ,pp. : 207-216

Elsevier

Access to resources Recommend Favorite

In-Vitro and Ex-Vivo Neutralizing Effect of Protamine Sulphate on the Anticoagulant Activity of a New Low Molecular Mass Heparin - a review of its toxicity

By Falkon L.   Gar M.   Gich I.   Fontcuberta J.  

Thrombosis Research, Vol. 89, Iss. 2, 1998-01 ,pp. : 79-83

Elsevier

Access to resources Recommend Favorite